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Abstract
Microfluidic devices are dominantly fabricated using the soft lithography microfabrication techniques and polydimethylsiloxane 
(PDMS) as a structural material.  Although the technique is applicable for the majority of microfluidic devices, it has limited use for 
the fabrication of microfluidic devices with immobilized biological specimen due to the low biocompatibility- a consequence of the 
plasma-assisted bonding step during the assembly of the final device. In this step, biological specimens within the microfluidic device 
are affected by strong plasma exposure which ultimately can degrade their biochemical activity and stability. To the best of our 
knowledge, this paper presents for the first time a method for increasing the biocompatibility of a conventional PDMS soft lithography 
process and enables fabrication of the microfluidic devices containing immobilized biological specimens.  Protection of the biological 
specimen during the plasma bonding step is ensured by placing a protective Polyvinyl Alcohol (PVA) nanofiber layer over the biological 
specimens. The method is verified against the conventional soft lithography method by fabricating microfluidic devices containing 
enzyme-filled microreactors and following enzymatic reactions.  It was shown that inadvantageous impact of the plasma is reduced by 
utilizing a protective PVA layer which ultimately preserves the specific activity and biochemical stability of the immobilized enzymes.
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1 Introduction
Over the last two decades, the interest in utilizing micro-
fluidic systems for various applications in biotechnology 
and biomedicine, mostly analysis and synthesis, has explo-
sively grown. These microfluidic devices enable integrating 
numerous laboratory functions on a single chip that extends 
only few millimeters to centimetres in size [1, 2]. These 
devices are suitably named Lab-on-a-chip (LoC) devices as 
they enable scaling of multiple laboratory processes down 
to a single chip format [2]. In contrast to conventional batch 
processes, LoC devices can offer a number of compelling 
advantages, including, but not limited to, higher throughput 
and massive parallelism, improved efficiency, closed-sys-
tem testing and better process control which reduces 
the potential of possible contamination and enables low 
response time and low reagent consumption [2, 3].
One of the key reasons for the popularization of LoC 
devices is their availability due to the ease of fabrication. 
In fact, it was the development of the novel microfab-
rication techniques over the recent years that led to the 
presence of these microscope slide-sized laboratories 
in every modern biochemical laboratory [1-4]. The cost 
reduction and production time decrease is what allowed 
a large number of laboratories to transfer their research 
from a large scale (batch processing) down to the micro 
scale. Nowadays, microfluidic devices are fabricated at 
low costs, allowing for the rapid and massive production 
of cost-effective microfluidic chips [1-4]. 
Devices can be fabricated from diverse materials such 
as polymers (e.g. Polydimethylsiloxane (PDMS)), ceram-
ics, semiconductors (e.g. silicon) and metals [5]. Choosing 
an optimal fabrication technique depends on the selected 
structural material and most common methods are soft 
lithography (dominantly used in combination with PDMS), 
metal deposition, etching, bonding, injection molding and 
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embossing [5]. Accessing a large number of materials and 
methods makes it possible to design microfluidic chips 
with application-specific features such as optical, biologi-
cal or chemical characteristics, which can then be rapidly 
prototyped at low production costs. The final choice of the 
material and the fabrication method depends on the tar-
geted biochemical application.
In the field of microfluidics, the PDMS has become the 
material of choice for the microfabrication of the microflu-
idic devices due to its excellent physical properties [1]. The 
PDMS material offers good thermal and chemical stabil-
ity- a crucial factor in biochemical applications, it is non-
toxic, inert, biocompatible, non-fluorescent and optically 
transparent down to the wavelengths of 300 nm [1, 2]. 
Although there are many methods for fabricating micro-
fluidic devices in PDMS, the most common approach is 
the soft lithography method. Over the years, the method 
has become standardized and it can offer fast, easy and 
cost-effective fabrication of microfluidic PDMS devices. 
The process revolves around three main steps: mask devel-
oping, PDMS casting and bonding [1, 2, 5]. In the first 
step, a photosensitive resist and a light source are used to 
create a mold (a footprint) of the network of microfluidic 
channels and structures [1]. In the second step, PDMS is 
casted onto the mold and cured at high temperatures in 
order to imprint the microfluidic channels and features 
from the mold into the PDMS. After the curing, PDMS is 
released and cut from the mold leaving the imprinted chan-
nels and features open. During the final step, the PDMS is 
bonded to a substrate (usually glass or other PDMS slide) 
to seal the channels and form a final microfluidic device. 
In order to achieve bonding, both substrate and patterned 
PDMS are exposed to a strong oxygen plasma etching and 
brought into contact immediately after the exposure in 
order to form a permanent bond [2] (cf. Fig. 1). 
Unfortunately, for the microfluidic applications that 
involve biological specimens, the bonding step of the soft 
lithography process represents a challenge since strong 
plasma exposure can effect the biochemical activity and 
stability of the specimen. This is the case when micro-
fluidic devices that host immobilized biological spec-
imens, often used in diagnostics [6, 7], synthesis [8] or 
analysis [9], need to be fabricated. For example, in the 
case of microfluidic chips hosting immobilized enzymes, 
the enzyme stability is imperative for ensuring their high 
kinematic activity. When exposed to the plasma etching, 
the plasma can affect the stability, therefore leading to 
reduced enzymatic activity and efficiency. Here, a method 
to protect enzymes, or other biological specimens, during 
the plasma exposure is truly a necessity.
The scope of this work is to further investigate the destruc-
tive effects of the inevitable plasma exposure on the biolog-
ical specimens, and to deliver a novel method that improves 
the applicability of the conventional soft lithography tech-
nique for fabricating microfluidic devices with immobilized 
specimens. We start by introducing the step-by-step con-
ventional soft lithography process. In Section 3, we intro-
duce microfluidic devices that host immobilized biological 
specimens, with a focus on LoC devices with immobilized 
enzymes. Section 4 gives a theoretical introduction of the 
novel fabrication technique, while Section 5 demonstrates 
the experimental validation of the proposed method. The 
final section compares and concludes the obtained results.
2 Conventional Soft Lithography 
The standard soft lithography process technique is illustrated 
in Fig. 1. The process is usually carried out in the clean room 
in order to minimize the risk of any contamination, however 
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Fig. 1 The step-by-step process of soft lithography with three main 
steps: mask developing, PDMS casting and bonding.
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the use of a clean room is not an absolute necessity except 
for the most demanding fabrication requirements [1, 2].
The process starts with designing the network of micro-
fluidic channels and features. The design is printed and 
used to form a mold (a footprint) of the microfluidic chan-
nels and structures. Here, photosensitive resist (usually 
SU-8) is spin-coated on the substrate (often Si wafer) in 
a controllable fashion depending on the desired thick-
ness. The resist is then pre-baked in order to evaporate 
its solvent and lastly exposed to a light source (UV in 
the case of the SU-8 resist) to create a pattern based on 
the designed mask. Optional post-exposure baking steps 
aid in cross-linking the exposed portions of the SU-8 in 
preparation for its development. Lastly, SU-8 is developed 
leaving the finished pattern of microfluidic channels on 
the substrate for the use in casting of the PDMS.
Preparation of the PDMS chip is carried out as an inde-
pendent step where curing agent and siloxane are mixed in 
order to prepare final PDMS polymer that is casted onto 
the fabricated SU-8 mold. Placing casted PDMS in an 
oven cures the PDMS, which can then be released from 
the mold and cut as desired. 
In the last step, released PDMS and the cover substrate 
(usually glass or PDMS slide) are bonded using the oxygen 
plasma to form the final microfluidic device. Here, plasma 
exposure is used to aid the bonding by modifying the sur-
face of both PDMS and the covering substrate. Untreated 
PDMS will not stick to any other substrate and it will be 
strongly hydrophobic [1]. For this reason, exposing PDMS to 
oxygen plasma reduces its hydrophobicity and aids bonding 
the PDMS to the glass substrate. To form a final microflu-
idic device, the two are brought into direct contact shortly 
after the plasma exposure (within the 60s after the exposure) 
which forms a permanent bond and seals the device [1, 2].
Over the last two decades, the process illustrated in 
Fig. 1 has been a method of choice for fabricating various 
microfluidic devices that target numerous applications, 
both in continuous and two-phase microfluidics [10-12].
In these applications, the fabrication of the microfluidic 
device and experimental testing of the device are carried 
out as two independent steps (cf. Fig. 2(a)). In these appli-
cations, biological specimens are introduced only during 
the experimental/testing phase. It is only at that last phase 
that the specimens are delivered to the device through the 
microfluidic tubes, through the inlets of the device, and 
further processed on the chip.
However, for some microfluidic applications, fabrica-
tion and testing of the device cannot be carried out as two 
independent steps. This is the case for microfluidic devices 
where biological specimens are required to be perma-
nently immobilized within the device [6-9]. This means that 
already at the fabrication phase, prior to assembling the final 
device, biological specimens are introduced into the device 
(cf. Fig. 2(b)). For these applications, conventional soft 
lithography process needs to be improved in order to protect 
immobilized specimens during the fabrication process. 
In the following section, we briefly introduce concepts 
of microfluidic devices that host immobilized biological 
specimens in order to carry out chemical synthesis and 
analysis. Specifically, we focus on presenting microreac-
tor LoC devices with immobilized enzymes [13-15].
3 LoC devices with immobilized enzymes
Compelling advantages of the microscale laboratory devices 
can be used to conduct and follow the biocatalytic (enzymatic) 
reactions in a more effective and controlled fashion then what 
conventional batch processing can offer [12, 13]. In these 
applications, biological specimens of an interest are enzymes 
(biocatalysts) while chambers on the microfluidic chip where 
reactions occur are termed as microreactors [16]. 
3.1 Enyzmes
Enzymes are macromolecular biocatalysts that serve for 
accelerating chemical reactions [16, 17]. These catalysts 
are not only important for optimal functioning of all living 
beings but are also widely used in diverse sectors of bio-
process technology due to their green chemistry [17]. For 
this reason, various research studies on enzymatic reac-
tions, more specifically enzymatic activity, productivity, 
stability, specificity and efficiency, have been proposed 
over the years [17-19].
Fig. 2 Different stages of introducing the biological specimens into the 
device: (a) Specimens are introduced after the fabrication was completed; 
(b) Specimens are introduced into the device during the fabrication.  
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Enzymes can be free to move (free enzyme system) or 
they can be attached to a surface (immobilized enzyme 
system) [13-15]. Nowadays, immobilized enzymes are pre-
ferred over their free counterparts due to the increased enzy-
matic stability over a considerably long period of time [17]. 
Immobilization of enzymes is a confinement of an enzyme 
to some sort of a biocompatible surface such as beads, gels, 
nanopores, magnetic nanoparticles, and recently, polymer 
nanofibers [13-15, 17]. Immobilization allows for enzymes 
to be held in place throughout the biochemical reaction, fol-
lowing which they are easily separated from the products 
and may be re-used for another set of biochemical reactions, 
therefore enabling enzyme recycling. 
Although various techniques were demonstrated suc-
cessful for enzyme immobilization, entrapment or cag-
ing of enzymes by covalent or noncovalent bonds within 
gels or electrospun nanofibers have truly revolutionized 
the world of enzyme immobilization. This is due to the 
wide applicability of the entrapping methods in the fields 
of chemistry, biomedicine biosensors and biofuels [17]. 
Moreover, a broad spectrum of structural materials avail-
able to construct the nanofibers makes the method suitable 
for various microfluidic applications. Fig. 3 shows SEM 
images of an enzyme immobilization within nanofibers of 
different diameters as a result of different electrospinning 
settings (see Section 4.3).
3.2 Enyzmatic microreactors
Microreactors are defined as miniaturized reaction sys-
tems that are often employed in biocatalytic applications 
where due to the small sizes enzymatic processes are more 
effective and economical [19]. In contrast to conventional 
batch methods of following the biocatalyctic reactions, 
LoC devices with microreactors offer accelerated process 
development, enhanced safety, stable and controlled tem-
perature distribution inside the reactor volumes, short 
reaction times and high throughput [19]. Moreover, micro-
reactors are characterized by an outstanding repeatabil-
ity and reproducibility- a key features in employing these 
structures in investigating enzymatic kinetics.
In biocatalytic applications, the efficiency of the micro-
reactor can be further improved by immobilization of 
enzymes inside the microreactors. This offers a high 
degree of re-usability of the biocatalyst which results 
with more economical and more environmentally friendly 
process [17, 19]. Eventually, integrating immobilized 
enzymes onto the LoC devices can offer a high throughput 
screening of enzymes and their substrates. This could lead 
to a wide range of potential applications of microreactors 
in biotechnology, as well as combinatorial chemistry and 
enzyme targeted drug search [17, 19].
Despite the rapid development of enzymatic microreac-
tors in the recent decade, important design and fabrication 
questions still remain unanswered, therefore limiting the 
possibilities of the research in this field [19]. Moreover, 
this results with the lack of the experimental validation 
of the already existing enzymatic microreactor models. 
In order to offer possibilities for further advancements in 
protein and enzyme research, the next section introduces 
a novel method for adopting conventional soft lithography 
process for the fabrication of LoC devices with microreac-
tors that host immobilized enzymes.
4 Novel fabrication method
Standard microfluidic chip is usually fabricated using 
the PDMS as a structural material and the soft lithogra-
phy process as a fabrication technique, due to their eas-
iness of use and fast prototyping [2]. It is then somewhat 
Fig. 3 Scanning Electron Microscopy (SEM) analysis of Lipase CaLB enzyme entrapped within the PLA nanofibers ranging from 200 nm to 700 nm.
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expected to use the availability of this conventional pro-
cess and rather than delivering a completely new fabrica-
tion method, to focus on finding a way to adopt the already 
standardized process for the fabrication of microfluidic 
device with biological specimen.
We start by introducing the general workflow of the 
novel fabrication technique, as shown on Fig. 4, followed 
by more details on the materials and methods of sub-steps 
of the proposed technique.
4.1 The general working principle
The proposed microfluidic device has two import-
ant parts: glass substrate holding the biological speci-
mens (enzymes, proteins or cells) and a PDMS chip with 
imprinted microchannels and microreactors. For this rea-
son, the fabrication process is divided into two indepen-
dent parts which can be performed in parallel, thus lead-
ing to even faster device prototyping. 
The complete fabrication process is shown in Fig. 4. 
The left part of the figure demonstrates a typical PDMS 
molding and casting process, used to fabricate a network 
of channels and microreactors inside the PDMS material. 
The right side of the figure demonstrates the multi-
step fabrication of the glass substrate with immobilized 
enzymes1. In the first step, an enzyme-enriched Polylactic 
acid (PLA) polymer solution is electrospun onto the clean 
glass substrate, thus forming a layer of nanofibers with 
immobilized enzymes. This layer is the layer that pro-
vides the enzymatic activity for the microfluidic chip. 
In the following step, laser engraving (or other patterning 
technique) is used to pattern the design of a microreac-
tor area on the electrospun nanofiber layer. Afterwords, a 
second layer of the Polyvinyl Alcohol (PVA) nanofibers is 
deposited on top of the first layer. The PVA layer does not 
hold immobilized enzymes and serves solely to protect 
the underlying layer of PLA nanofibers during the forth-
coming plasma treatment. To make the design of the two 
layers of nanofibers compatible, the design of a microre-
actor area is again engraved in the PVA layer in the same 
manner as previously for the PLA layer.
To construct the final microfluidic device, the PDMS 
chip and the glass substrate with the nanofibers are 
exposed to plasma. Bringing the two parts into direct con-
tact after the exposure, the final device is assembled and 
fabrication process is completed. 
1 The process can be applied for fabricating glass substrates with other 
immobilized biological specimens such as proteins or cells. 
4.2 Fabricating the PDMS chip
To fabricate the PDMS chip, the siloxane oligomer and 
cross-linker/curing agent (Sigma-Aldrich, Sylgard 184) 
are thoroughly mixed at a ratio of 10:1 by weight and 
afterwards degassed in a vacuum chamber. The PDMS 
pre-polymer is poured/casted over the silicon master mold 
that was SU-8 patterned using the conventional photoli-
thography. Casting the PDMS over the mold, the PDMS 
conforms to the shape of the master and replicates its fea-
tures with a high resolution [1, 2]. The curing or cross-link-
ing of the PDMS took place at room temperature over the 
period of 24 hours. As an alternative, the curing can be 
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Fig. 4 A novel method  for fabricating microfluidic microreactor 
devices with immobilized enzymes. The process is divided into 
two independent steps: (left) conventional PDMS molding and 
casting for fabricating PDMS chip; (right) fabricating glass 
substrate that holds immobilized enzymes. 
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accelerated by enhancing the temperature e.g. (70 ºC for 
60 min). The PDMS can then be peeled off from the mold 
leaving the final PDMS chip. 
4.3 Fabricating the glass substrate with the enzyme
A microscope glass slide (1mm in thickness), used as a sub-
strate for the nanofibers, was carefully cleaned using an 
IPA (Isopropyl alcohol) and a clean-room tissue to remove 
the dust. In this step, the minute amount of IPA applied to 
the layers via the tissue evaporates in a few seconds after 
the application and does not affect the following process.
To fabricate nanofibers with immobilized enzymes, elec-
trospinning as the most common, simple and versatile pro-
cess for the production of fine fibers is used [20]. Using the 
electrostatic field, the technique allows for the production 
of long, three-dimensional, ultrafine fibers with diameters 
in the range of a few micrometres to nanometres [13]. For 
an enzyme entrapment within the nanofibers, a freshly 
prepared CaLB as lyophilized enzyme powder was 
added to the PLA polymer to form a 10% enzyme-poly-
mer mixture. The resulting mixture was agitated in an 
ultrasound bath for 25 min and then electrospun onto 
the glass substrate. Electrospinning experiments were 
performed at room temperature (24 ± 2 C) using a spe-
cially designed in-house tool. By varying parameters, 
such as the applied voltage (10-30 kV) and the distance 
from the polymer needle to the glass substrate mounted on 
the collector plate it is possible to generate nanofibers of 
varying parameters, as previously shown in Fig. 3. 
In order to engrave the layouts of the microreactors 
onto the nanofiber layer, laser cutting is used. In this 
work, solid-state, 355 nm Nd:YAG (neodymiumdoped 
yttrium aluminium garnet) laser is used as it offers con-
trollable output power and absolute precision of 1µm 
which allows for precise layout patterning. Moreover, the 
controllable output power makes this laser more suitable 
for the use with the thin substrates and with the biological 
specimens, since the damage caused by the heat trans-
fer can be minimized, thus making the engraving process 
more efficient and more stable.
To protect the layer of nanofibers with the immobi-
lized CaLB enzymes, a sacrificial layer of PVA nanofibers 
is electrospun on top of the first PLA enzyme-enriched 
layer. The PVA is a non-toxic, water-soluble synthetic 
polymer with a high degree of resistance for the plasma2. 
2  Behavior of the PVA material under the plasma exposure was 
observed during the number of experimental trials.
The PLA deposition is a critical step for enabling further 
fabrication and ensuring a correct functionality of the 
device. During the electrospinning of PVA, it is neces-
sary to assure that the underlying PLA layer with enyzmes 
is completely covered with the top PVA layer. Graphical 
illustration of the protective PVA layer is shown in Fig. 5. 
 In the following step, the PVA layer is laser patterned 
using the same microreactor design that was used to pat-
tern the PLA layer. An example of a microfluidic chip with 
two layers of laser engraved nanofibers is shown in Fig. 6.
4.4 Plasma bonding
In the final step, the microfluidic chip is assembled by 
exposing the glass substrate with nanofibers, together 
with the PDMS chip, to oxygen plasma for 30 seconds. 
Within the 60 seconds after the exposure, the two parts 
are brought into direct contact to form a permanent bond 
and seal the device. The strong strength of the plasma-as-
sisted bonding ensures that no leaking will occur during 
the testing of the device and provides the opportunity to 
re-use the device for multiple experiments.
PDMS
- enzyme- nanofibers - plasma
PLA
PVA
PDMS
PLA
Fig. 5 Exposing PLA and PVA to plasma: (left) having no protection on 
top of the PLA nanofiber layer with enyzmes, the plasma can penetrate 
through the fibers and effect the stability of the immobilized enzymes; 
(right) having high resistance layer of PVA nanofibers on top of the 
PLA layer protects the enzymes during the plasma exposure.
Fig. 6 An example of laser engraved microreactor layout on two 
layers of nanofibers: PLA layer with immobilized enzymes as a first 
layer, followed with the protective PVA layer.
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5 Experimental validation
To validate that the proposed method can truly be used 
in fabricating LoC devices with biological specimens, we 
have fabricated a microfluidic device with enzyme-filled 
microreactors according to the design shown in Fig. 6. 
Before presenting the results collected from the biocat-
alytic measurements, we give a brief background on the 
principle of microreactors and enzymatic activity.
5.1 The principle of the microreactor stage 
In this work, the reactor stage is designed in a form of 
cylindrical chambers (hollows) inside the PDMS material, 
whose content are nanofibers with immobilized enzymes. 
When reactor holds supporting materials such as nano-
fibers, and biocatalyst is immobilized onto their surfaces, 
it is defined as the packed-bed reactor [22]. As shown in 
Fig. 7, in the basic working principle, the reaction fluid 
enters the packed bed reactor, the reaction with biocata-
lyst develops in the microreactor stage, and outlet fluid is 
collected at the end of the microreactor. The target mol-
ecules of the enzymes dissolved in the reaction fluid is 
known as their substrate, and it is selectively bonded to 
the binding site of the enzyme that further catalyses the 
transformation of the substrate to a product [15]. In this 
work, an enzyme CaLB catalyses the transformation of 
the substrate p-Nitrophenyl palmitate (pNPP) to the prod-
uct p-nitrophenol (pNP). The enzymatic reaction takes 
place inside the microreactor area, as shown in Fig. 7.
5.2 Materials and Methods
5.2.1 Microreactor specifications 
After electrospinning the nanofibers with immoblized 
CaLB enzyme, the electrospun mass is measured to be 
3060 mg (3000 mg of PLA solution and 60 mg enzyme).
Considering that PLA solution is 10 % w/w solution, 
this implies that total chip holds 300 mg of PLA poly-
mer. Therefore, at the end of electrospinning process the 
chip hosts 300 mg of PLA and 60mg of CaLB enzyme, 
which means that enzyme/polymer ratio on the chip is 
60/300 = 20 %. In average, it was measured that every elec-
trospun chip carries 2-3 mg of CaLB enzyme. Moreover, 
the complete microreactor area chamber is measured to 
be as A
chamber
 = 21 × 4,635 mm2 = 97.33 mm2, while the 
total chip has the area of A
chip
 = 650 mm2. This implies 
that microreactor chamber area is 15 % of the total chip 
area. This further implies that the 15 % of total 2-3 mg of 
electrospun CaLB enzyme is contained in the microreac-
tor. Finally, this gives the approximation of the amount of 
CaLB enzyme in every chamber of 15µg, or in total micro-
reactor stage of 0.32 mg. 
5.2.2 Materials and tools
PLA (D-isomer Polylactic Acid \10 %, PURASORB PL 
24) was obtained from PURAC (Gorinchem, Netherlands). 
Solvents (chloroform and ethanol) were obtained 
from Molar Chemicals (Budapest, Hungary). N,N- 
Dimethylformamide (DMF) was obtained from Merck 
(Budapest, Hungary). PLA solution is 10 % m/m (9 % 
polymer and 91 % solvent). CaLB as lyophilized enzyme 
powder (recombinant C. antarctica lipase B) was obtained 
from c-LEcta (Leipzig, Germany). For an enzyme entrap-
ment within the nanofibers, the PLA solution (PLA solved 
in chloroform and dimethylformamide in 6/1 ratio) with 
CaLB as lyophilized enzyme powder was prepared where 
1 g of PLA solution contains 10mg of CaLB enzyme pow-
der. Since PLA polymer solution is 10 % polymer and 90 % 
solvent, the final polymer emulsion contains 10 % enzyme. 
Silicon Elastomer kit for fabricating PDMS chip was 
obtained from Sigma-Aldrich (Saint Louis MO, USA). To 
pattern the nanofibers, an Nd:YAG (AVIA Coherent, USA) 
laser was used. For the purpose of plasma treatment, Femto 
plasma cleaner (Diener electronics, Germany) was used. 
To follow the enzyme kinetics, gaschromatography(GC) 
on an Agilent 4890 equipment using Hydrodex b-6TBDM 
column (Machery-Nagel, 25m×25mm×0.25 µm, heptakis-
(2,3-di-Omethyl-6-O-t-butyldimethylsilyl)-b-yclodextrin) 
was used. Protective PVA solution was prepared with 
aqueous solvent (675 mg: 10 m/m% PVA in distilled water).
5.2.3 The substrate-product transformation
The assay was performed by measuring the increase in the 
absorbance expected at around 350-400 nm produced by 
reaction
fluid outlet
microreactor stage
O N2
 O
 O
n
CH3
p-Nitrophenyl palmitate
enzyme (CaLB)
H O2
 O
n
CH3HO
+
O N2 OH
p-nitrophenol
Fig. 7 Packed-bed reactor: the enzyme-substrate reaction between 
the immobilized enzyme CaLB and the reaction fluid p-Nitrophenyl 
palmitate takes place inside the microreactor stage.
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the release of a product p- nitrophenol in the hydrolysis 
of 0.4 mM pNPP (MW = 377:52 g/mol) in a Phosphate-
buffered saline (PBS) buffer (m = 0.1M, pH = 7.5) at the 
temperature of 30 ºC. To make a final reaction fluid, 7.8 mg 
of pNPP was solved in 20 ml PBS buffer. This stock solu-
tion was mixed for 27 hours to be diluted completely for 
the on-chip reaction. Reaction fluid enters the chip over 
the inlets with input flow rate in the range of 1- 5 µL/min. 
The substrate-enzyme reaction is carried out in situ, and 
the product is collected at the output. 
5.3 Measurements
For following the enzyme kinetics (parameters that 
describe the rate of substrate-product transformation) we 
observed the conversion rate (c), enantiomeric excess (ee), 
enantiomeric ratio (E), and specific activity (U
B 
) of an 
enyzme, as a measurement of an enzyme purity and reac-
tion rates. The measurements were obtained using the gas 
spectroscopy (GC) tool.
Table 1 gives the values of the kinetic parameters for the 
two types of measurmenets: i) the measurements carried 
out when enzyme-enriched PLA nanofibers were directly 
exposed to the plasma (conventional fabrication process) 
and ii) the measurements carried out when protective 
PVA layer is electrospun on top of the enzyme-enriched 
PLA layer (the novel proposed method). As it can be seen 
in Table 1, a significant increase in all reaction parame-
ters can be noticed when enzymes are protected by the 
PVA nanofiber layer. The values obtained demonstrate the 
importance of utilizing the protective PVA layer to pro-
tect the underlaying enzymes. Moreover, two sets of tests 
were carried out for the same conditions to further verify 
the obtained results. As it can be seen in Table 1 (row 2 
and 4, as well as row 6 and 8) similar results are obtained 
for these tests (small deviations in presented results can be 
reasoned by possible ununiformity of plasma in the cham-
ber as well as the change of the room temperature while 
conducting experiments).
6 Conclusion
In this work, we have proposed a novel technique for fab-
ricating biocompatible microfluidic chips that host immo-
bilized biological speciments. The technique was opti-
mized for the purpose of fabricating LoC devices that host 
nanofiber-immobilized enzymes inside the microreactor 
stage. The proposed method solves the great challenge of 
the conventional fabrication technique by means of pro-
tecting the immobilized enzymes from the plasma treat-
ment which was a true necessity. Here, a novel approach 
utilizing protective PVA layer on top of an enzyme-en-
riched PLA layer, was introduced and experimentally 
verified. Results demonstrated that the PVA layer can 
successfully protect the enzymes during the plasma treat-
ment and therefore ensure their higher enzyme activity 
for a later use. 
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Table 1 Catalytic behavior of the CaLB enyzmes for different fabrication 
methods: Polymer type PLA specifies that enzyme-enriched layer of 
PLA nanofibers was directly exposed to the plasma, while PLA+PVA 
corresponds to the novel fabrication method. By comparing the values 
of the enzymatic parameters, it can be noticed that protective PVA layer 
contributes to higher catalyctic activity of the immobilized enzymes.
Polymer 
type
Plasma 
time (s)
RT3 
(h)
c
(%)
ee (%) E U
B
PLA 12 2 0.8 77.8 8.1 2.6
PLA+ 
PVA
12 2 1.6 91.1 22.1 5.3
PLA 12 2 0.7 92.5 26.2 2.8
PLA+ 
PVA
12 2 0.9 92.3 25.3 3.0
PLA 12 4 2.0 97.6 89.5 3.3
PLA+ 
PVA
12 4 4.3 98.1 100 7.2
PLA 12 4 1.5 96 51.3 3
PLA+ 
PVA
12 4 1.8 97.2 71.8 3
3 Reaction Time- period needed to complete the reaction for the given 
volume of the reagents
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